Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Fabozzi

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Critical Reviews in Oncology/Hematology|December 28, 2024
<sup>131</sup>I-mIBG therapy in relapsed/refractory neuroblastoma: A weapon from the future pastFrancesco Fabozzi, Maria Felicia Villani, Francesca Del Bufalo, et al.
Scientific Reports|November 7, 2023
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case seriesMaria Antonietta De Ioris, Francesco Fabozzi, Francesca Del Bufalo, et al.
Frontiers in Oncology|January 23, 2024
Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemiaFrancesco Fabozzi, Rosalba Carrozzo, Mariachiara Lodi, et al.
Diagnostics (Basel, Switzerland)|December 23, 2022
The Pitfall of Ganglioneuroblastoma-Nodular Diagnosis: Clinical and Imaging Considerations over a Rare Bifocal Sporadic CaseClaudio Montante, Francesco Fabozzi, Maria Felicia Villani, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 4, 2023
Safety and Efficacy of Mek Inhibitors in the Treatment of Plexiform Neurofibromas: A Retrospective StudyAntonella Cacchione, Francesco Fabozzi, Andrea Carai, et al.
European Journal of Pediatrics|December 14, 2023
Current practices for nutritional evaluation and care during the treatment of pediatric oncology patients: a survey among AIEOP centersFrancesco Venturelli, Davide Leardini, Francesco Baccelli, et al.
Pediatric Blood & Cancer|May 19, 2025
Food Safety Practices and Foodborne Illness in Italian Pediatric Oncology and Hematology Centers: A Survey on Behalf of the Infectious Disease Working Group of AIEOPDavide Leardini, Gianluca Bossù, Francesco Venturelli, et al.
Nature Medicine|August 21, 2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Nature Medicine|September 9, 2025
Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Nature Medicine|January 15, 2025
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastomaConcetta Quintarelli, Francesca Del Bufalo, Maria Antonietta De Ioris, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Critical Reviews in Oncology/Hematology|December 28, 2024
<sup>131</sup>I-mIBG therapy in relapsed/refractory neuroblastoma: A weapon from the future pastFrancesco Fabozzi, Maria Felicia Villani, Francesca Del Bufalo, et al.
Scientific Reports|November 7, 2023
Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case seriesMaria Antonietta De Ioris, Francesco Fabozzi, Francesca Del Bufalo, et al.
Frontiers in Oncology|January 23, 2024
Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemiaFrancesco Fabozzi, Rosalba Carrozzo, Mariachiara Lodi, et al.
Diagnostics (Basel, Switzerland)|December 23, 2022
The Pitfall of Ganglioneuroblastoma-Nodular Diagnosis: Clinical and Imaging Considerations over a Rare Bifocal Sporadic CaseClaudio Montante, Francesco Fabozzi, Maria Felicia Villani, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 4, 2023
Safety and Efficacy of Mek Inhibitors in the Treatment of Plexiform Neurofibromas: A Retrospective StudyAntonella Cacchione, Francesco Fabozzi, Andrea Carai, et al.
European Journal of Pediatrics|December 14, 2023
Current practices for nutritional evaluation and care during the treatment of pediatric oncology patients: a survey among AIEOP centersFrancesco Venturelli, Davide Leardini, Francesco Baccelli, et al.
Pediatric Blood & Cancer|May 19, 2025
Food Safety Practices and Foodborne Illness in Italian Pediatric Oncology and Hematology Centers: A Survey on Behalf of the Infectious Disease Working Group of AIEOPDavide Leardini, Gianluca Bossù, Francesco Venturelli, et al.
Nature Medicine|August 21, 2025
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Nature Medicine|September 9, 2025
Publisher Correction: GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trialFranco Locatelli, Daria Pagliara, Maria A De Ioris, et al.
Nature Medicine|January 15, 2025
Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastomaConcetta Quintarelli, Francesca Del Bufalo, Maria Antonietta De Ioris, et al.
Pageof 4